APO-DAPAGLIFLOZIN

Resumen del producto

About APO-DAPAGLIFLOZIN

APO-DAPAGLIFLOZIN is a prescription medication containing the active ingredient Dapagliflozin, used in the treatment of type 2 diabetes. It belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by reducing the amount of glucose reabsorbed by the kidneys and promoting its excretion in the urine.

Key Benefits & Uses

• Improves glycemic control in adults with type 2 diabetes, reducing HbA1c levels and fasting plasma glucose.
• Helps to reduce body weight and blood pressure in patients with type 2 diabetes.
• May reduce the risk of major adverse cardiovascular events, such as heart attack, stroke, or death, in patients with established cardiovascular disease or multiple cardiovascular risk factors.

Active Ingredient & Action

Dapagliflozin, the active ingredient in APO-DAPAGLIFLOZIN, works by inhibiting the SGLT2 protein in the kidneys, which reabsorbs glucose from the filtrate back into the bloodstream. By blocking this protein, Dapagliflozin increases the excretion of glucose in the urine, reducing blood glucose levels and improving glycemic control.

Important Notes

Before taking APO-DAPAGLIFLOZIN, inform your doctor about any kidney problems, urinary tract infections, or a history of pancreatitis. Monitor your blood sugar levels regularly, and adjust your diet and exercise routine as needed. Do not use APO-DAPAGLIFLOZIN if you are pregnant or breastfeeding, or if you have a history of ketoacidosis or severe dehydration.